12156844 · Active · incorporated 7 years ago · London
Biotech Biotech & Life Sciences Drug Discovery Healthcare Series B+
Alchemab Therapeutics is a biopharmaceutical company that develops therapeutic antibodies by harnessing the immune system.
Alchemab Therapeutics Ltd is a private limited company registered at Companies House under number 12156844, incorporated on 14 August 2019, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 91 filings for this company, including 6 funding rounds. Its most recent round closed in July 2026, raising £25m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 6 | Jul 2026 | £25m | £1.42 |
| Round 5 | Nov 2025 | £25.2m | £0.74 |
| Round 4 | Jul 2024 | £20m | £1.29 |
| Round 3 | Oct 2022 | £20m | £1.29 |
| Round 2 | Apr 2021 | £14m | £1.29 |
| Round 1 | Aug 2021 | £6m | £0.50 |
Showing the 12 most recent of 91 filings.
See the complete cap table with every shareholder, founder tags, dilution across 34 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.